Quel est le prix pour Medigene AG (MDG1)

Le prix pour Medigene AG (MDG1) est $0.14942078

Quelle est la capitalisation boursière pour Medigene AG (MDG1)

La capitalisation boursière pour Medigene AG (MDG1) est $3.86M

Medigene AG (MDG1) Divisions d'Actions

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

Année	Division	Multiplicateur	Multiplicateur cumulatif
2024-08-29	1:2	x0.5	x0.125
2013-09-03	1:4	x0.25	x0.25

Année

Division

Multiplicateur

Multiplicateur cumulatif

2024-08-29

1:2

x0.5

x0.125

2013-09-03

1:4

x0.25

Entreprise	Nombre de divisions d’actions	Multiplicateur cumulatif	Pays
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Entreprise

Nombre de divisions d’actions

Multiplicateur cumulatif

Pays